What is NDC 60505-6435?

60505-6435 is the product NDC for eribulin mesylate, Eribulin mesylate .5 mg/mL injection, listed with the FDA by Apotex Corp.. It has 1 package NDC, shown above in 10- and 11-digit form.

Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for eribulin mesylate?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

eribulin mesylate NDC 60505-6435 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60505-6435Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60505-6435Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60505-6435-0	6050564350060505643500	1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSEMarketed from Mar 19, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): eribulin mesylate
Generic name (nonproprietary): eribulin mesylate
Active ingredients: Eribulin mesylate — .5 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: Apotex Corp.NDC labeler code 60505
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218047
Marketing start: Mar 19, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Microtubule Inhibition (Physiologic effect)
Identifiers: Product ID 60505-6435_7324bf15-e9e4-547d-b434-0731724875ebSPL ID 7324bf15-e9e4-547d-b434-0731724875eb
Pharmacologic class: Microtubule Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N460505643500 followed by a unit qualifier and the quantity

Package 60505-6435-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 60505-6435

What is NDC 60505-6435?: 60505-6435 is the product NDC for eribulin mesylate, Eribulin mesylate .5 mg/mL injection, listed with the FDA by Apotex Corp.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: eribulin mesylate.
What is the active ingredient?: Eribulin mesylate.
Who is the labeler?: Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for eribulin mesylate?: 14 other product NDCs are listed under this name. See all eribulin mesylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other eribulin mesylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Eribulin Mesylate	Eribulin mesylate .5 mg/mL	InjectionIntravenous	XGen Pharmaceuticals DJB, Inc.	39822-2080	39822-2080-01
Eribulin Mesylate	Eribulin mesylate .5 mg/mL	InjectionIntravenous	Dr. Reddys Laboratories Inc	43598-125	43598-0125-11
Eribulin Mesylate	Eribulin mesylate .5 mg/mL	SolutionIntravenous	Northstar Rx LLC	72603-368	72603-0368-01
Eribulin Mesylate	Eribulin mesylate .5 mg/mL	SolutionIntravenous	BluePoint Laboratories	68001-656	68001-0656-41
Eribulin Mesylate	Eribulin mesylate .5 mg/mL	InjectionIntravenous	Kindos Pharmaceuticals Co., Ltd.	40033-364	40033-0364-01
Eribulin Mesylate	Eribulin mesylate .5 mg/mL	InjectionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-770	68462-0770-20
Eribulin Mesylate	Eribulin mesylate .5 mg/mL	InjectionIntravenous	Sandoz Inc	0781-3391	00781-3391-94
Eribulin Mesylate	Eribulin mesylate .5 mg/mL	InjectionIntravenous	Sun Pharmaceutical Industries Limited	70095-080	70095-0080-01
Eribulin Mesylate	Eribulin mesylate .5 mg/mL	InjectionIntravenous	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	71731-4171	71731-4171-01
Eribulin Mesylate	Eribulin mesylate .5 mg/mL	InjectionIntravenous	Baxter Healthcare Company	10019-080	10019-0080-01

All 15 eribulin mesylate NDCs

Other NDCs under ANDA 218047

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218047
Product	Strength	Form · route	Labeler	Product NDC
eribulin mesylate	Eribulin mesylate .5 mg/mL	InjectionIntravenous	Apotex Corp.	60505-6289
eribulin mesylate	Eribulin mesylate .5 mg/mL	InjectionIntravenous	Gland Pharma Limited	68083-592